SUPERNUS PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Supernus Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2011 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $33.6M, a 13.3% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $33.6M -$5.17M -13.3% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $35.9M -$2.6M -6.75% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $38.4M -$1.82M -4.52% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $37.5M -$2.3M -5.78% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $38.8M -$2.47M -5.98% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $38.5M -$8.86M -18.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $40.2M -$8.8M -18% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $39.8M -$9.43M -19.1% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 $41.3M +$1.16M +2.88% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $47.3M +$6.66M +16.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $49M +$18.7M +61.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $49.2M +$5.98M +13.8% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $40.1M +$21.8M +119% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $40.7M +$23.6M +138% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $30.3M +$29.7M +5524% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $43.2M +$21.4M +97.5% Dec 31, 2020 10-K 2022-04-13
Q3 2020 $18.3M +$17.8M +3092% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $17.1M +$16.5M +2846% Jun 30, 2020 10-Q 2020-08-17
Q1 2020 $538K -$87K -13.9% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $21.9M +$21.5M +5662% Dec 31, 2019 10-K 2021-03-08
Q3 2019 $574K -$208K -26.6% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $581K -$171K -22.7% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $625K -$110K -15% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $380K -$9K -2.31% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $782K +$414K +113% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $752K +$403K +115% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $735K +$385K +110% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $389K +$58K +17.5% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $368K +$36K +10.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $349K +$29K +9.06% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $350K +$39K +12.5% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $331K +$13K +4.09% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $332K +$10K +3.11% Sep 30, 2016 10-Q 2017-01-20
Q2 2016 $320K -$1K -0.31% Jun 30, 2016 10-Q/A 2017-01-23
Q1 2016 $311K -$10K -3.12% Mar 31, 2016 10-Q/A 2017-01-20
Q4 2015 $318K -$42K -11.7% Dec 31, 2015 10-K 2017-03-16
Q3 2015 $322K -$38K -10.6% Sep 30, 2015 10-Q/A 2017-01-20
Q2 2015 $321K -$40K -11.1% Jun 30, 2015 10-Q/A 2017-01-23
Q1 2015 $321K -$39K -10.8% Mar 31, 2015 10-Q/A 2017-01-20
Q4 2014 $360K -$1.01M -73.6% Dec 31, 2014 10-K/A 2017-01-20
Q3 2014 $360K $0 0% Sep 30, 2014 10-Q/A 2017-01-20
Q2 2014 $361K +$1K +0.28% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $360K -$3K -0.83% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 $1.37M +$1.03M +309% Dec 31, 2013 10-K 2015-03-12
Q3 2013 $360K +$305K +555% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $360K +$305K +555% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $363K +$302K +495% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $334K +$279K +507% Dec 31, 2012 10-K 2014-03-21
Q3 2012 $55K Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $55K Jun 30, 2012 10-Q 2012-08-13
Q1 2012 $61K Mar 31, 2012 10-Q 2012-06-08
Q4 2011 $55K Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.